Sign in to view content

Intravitreal Bevacizumab vs. Bevacizumab with Dexamethasone for the Treatment of Exudative Age-Related Macular Degeneration

Reda Issa, MD

Video
Published 2019

Related

Episode 2: Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration with Dr. Brian Ballio
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), in Subjects With Wet AMD
Vrinda S. Hershberger, MD, PhD
On Demand Cases, Courses, and Papers
2021
Optos Silverstone Fundus Image of a 4-Point Scleral Fixation Akreos AO60 with Gore Tex Suture
Jesus Lozano, MD
Retina Image Bank: Images of the Week
2022

Category: AMD-Neovascular

See more